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We undertook a multicenter, parallel treatment arm, randomized controlled trial to compare the outcomes after surgery for the treatment of lesser digital hammertoe using either a Kirschner wire or a 2-piece intramedullary, stainless steel implant for fixation of the proximal interphalangeal joint. Our primary aim was to compare the incidence of arthrodesis and complications, and our secondary aim was to compare the subjective foot-related outcomes measured using the Bristol Foot Score and the Foot Function Index, stratified by fixation group. We hypothesized that the use of the dual-component implant would result in greater patient satisfaction, a greater incidence of radiographic arthrodesis, and fewer complications after hammertoe repair. The overall mean age of the participants was 58.72 AE 13.48 (range 18 to 84) years, their mean body mass index was 30.14 AE 6.55 (range 20.7 to 46.98) kg/m 2 , and no statistically significant differences in the demographic variables were present between the treatment groups at baseline or during the follow-up period. Of the 91 participants, 46 (50.55%) were randomly allocated to the Kirschner wire group and 45 (49.45%) to the intramedullary implant group. No statistically significant differences were observed between the 2 fixation groups in the incidence of complications; however, the 2-piece intramedullary implant group was associated with a greater mean Bristol Foot Score and Foot Function Index score and a greater incidence of fusion.
Ó 2016 by the American College of Foot and Ankle Surgeons. All rights reserved.
Hammertoe (HT) is a prevalent deformity of the lesser toes, accounting for 34.5% of all foot and ankle conditions in older adults (1) and observed in 32% of patients at a Veterans Affairs diabetes clinic (2) . It is characterized by concomitant flexion of the proximal interphalangeal joint (PIPJ) and hyperextension of the metatarsophalangeal joint (MTPJ) (3, 4) . Numerous procedures have been described for the correction of the HT deformity, ranging from interphalangeal (IP) arthroplasty with or without tendon transfer and temporary Kirschner wire (K-wire) stabilization to PIPJ fusion using any of a wide range of fixation devices, including a K-wire (5, 6) or wires (7), sutures (8) , single and multicomponent internal fixation devices (9) (10) (11) (12) (13) (14) (15) , PIPJ fusion augmented with a bone graft (16) , and combinations of interphalangeal (IP) manipulations with MTPJ relocation and stabilization (17) . Regardless of the surgical technique used, the goals of surgery are to correct the deformity (or limit its progression) and alleviate pain. Thus, the surgery should create a lasting correction, improve overall gait and ambulation function, and minimize the risk and incidence of postoperative complications. Although static deformities often respond to PIPJ arthroplasty, surgeons tend to fuse the PIPJ when the deformities are dynamic in origin. In general, for PIPJ arthrodesis, especially when multiple lesser digits are involved, an axial intramedullary K-wire exiting the distal aspect of the toe percutaneously is used to splint the fusion interface and the distal IP joint and, if indicated, the MTPJ (assuming the deformity is dynamic in origin). PIPJ fusion with the use of a K-wire was, for the purposes of the present report, considered standard therapy.
In most cases, HT surgical repair will be successful; however, complications can occur. The common complications include floating toe (18, 19) , residual hyperextension of the MTPJ after resection arthroplasty (20) , bone regeneration after arthroplasty (21) , secondary distal IP joint plantar contracture after PIPJ fusion (14) , nonunion after attempted PIPJ fusion (22) , internal fixation displacement (14) , IP malunion (14) , and pin tract infection (23) . When a K-wire is used, mechanical flexure of the fixation construct can contribute to pin loosening, rotation, migration, pin tract infection, pin deformation, fibrous pseudoarthrosis, difficult removal, and, even, pin breakage. The use of K-wires, however, has distinct advantages. For example, an axial, intramedullary percutaneous K-wire that exits the tip of the toe and is maintained in place for 6 weeks has been associated with a lower incidence of recurrent misalignment (with no increase in K-wire-related complications) (24) . However, many patients find that living with K-wires protruding from the tips of their toes for 6 weeks is not only inconvenient (e.g., no showering, no regular shoe gear) and sometimes painful, but is also anxiety-triggering owing to the prolonged disruption of body image (25) . For both patients and clinicians, removal of K-wires can also be aggravating. This in-office procedure can be time-consuming and painful. A fixation device that can be implanted and maintained indefinitely within the PIPJ fusion mass offers distinct advantages, obviating the risk of pin tract infection, percutaneous hardware migration, the need for pin maintenance, and planned subsequent removal of the device. One disadvantage of an implantable device is the potential for difficulty in properly inserting the device such that it will adequately stabilize the fusion interface without being prominent, unstable, or misaligned. Also, should the need arise, the implant can be difficult to explant. Another potential disadvantage is that it is likely to cost more than a single K-wire, simply in terms of per item device costs.
To compare the efficacy of a dual-component, intramedullary, stainless steel (DCIMSS) implant with that of K-wire fixation of the PIPJ for correction of lesser digital HT deformity, we undertook a multicenter, randomized controlled trial (RCT) and evaluated the subjective patient-oriented outcomes, including pain, and the incidence of radiographic evidence of successful arthrodesis and complications after surgery. We hypothesized that use of the DCIMSS implant would result in greater patient satisfaction and pain relief, particularly early in the postoperative phase, a greater incidence of successful radiographic arthrodesis, and fewer complications after surgical repair of the toes.
Patients and Methods
We undertook a multicenter, RCT involving 2 parallel treatment groups that were equally allocated in a 1:1 ratio. In the present RCT, the K-wire fixation group represented the standard therapy, and those participants allocated to receive the DCIMSS implant were considered the intervention or intramedullary implant group. The entire study was initiated and designed by three of us (R.J., A.L., D.S.M.), without input from the study sponsor. The study sponsor was approached only after the investigation had been designed and a budget and timeline had been determined. An a priori sample size estimate using a 2-sample comparison of means according to the incidence of fusion reported in previous publications (26, 27) , indicated that approximately 40 participants would be required in each treatment group to identify a statistically significant difference (p .05; power 0.8) if one existed regarding successful fusion of the PIPJ. To account for a potential loss of 10% of patients in each group, we planned to recruit ! 45 participants in each arm of the investigation. Those individuals who met the inclusion criteria were randomly allocated in a 1:1 ratio to the standard therapy group or the DCIMSS group. Simple random treatment allocation, by patient, was determined using a random number generator (Microsoft
Ò
Excel
Ò 2008 for Mac, version 12.3.6; Redmond, WA). Odd numbers allocated patients to the K-wire group and even numbers to the intramedullary implant group.
Sequentially numbered, opaque, sealed envelopes containing the designated treatment allocation were distributed to the investigating surgeons, each of whom opened the assigned envelops to identify the form of fixation to be used to stabilize the PIPJ at HT repair. With the exception of the study administrator, the treatment allocation was not disclosed to the surgeon or the patient until just before the operation, making it highly unlikely that a participating surgeon or patient could systematically "guess" which intervention would be used. If a patient with >1 HT was enrolled, the random treatment allocation determined that the intervention would be performed on all the involved toes (on the same foot). We defined the primary efficacy endpoint as the foot-related quality of life (QOL) at 3 months after surgery, because we believed that at such a time successful arthrodesis would be evident both clinically and radiographically in most cases. We also decided that !6 months of follow-up would enable us to identify almost every postoperative complication that might develop in relation to the interventions we were interested in analyzing. Despite our interest in foot-related QOL, we did not find a published report that had used a foot-related QOL questionnaire or survey known to produce valid information specifically for digital surgery in the foot. Therefore, we resorted to comparisons of radiographic evidence of PIPJ arthrodesis. We did so because we were trying to estimate the appropriate number of patients required to identify a statistically significant difference, if one existed. In addition, we further estimated that successful fusion was strongly associated with foot-related QOL after HT surgery. In essence, we compounded the estimate, which we believe was as good as possible given the data published when we were planning the surgical experiment. We also added >10% to this sample size estimate, in each arm of the experiment, in an effort to cushion the estimate.
All coinvestigators were thoroughly trained regarding the study method, ethical human research conduct, the ongoing informed consent process for human research, and the interventions and outcomes assessments used in the present study. Two clinical research fellows and two podiatric surgical residents contributed to the data procurement and maintenance and radiographic interpretation. A nonsurgeon (Arne Landsman; study administrator), who did not participate in recruitment or treatment or assessment of any of the participating patients, maintained the random treatment allocation key.
The data were procured at each study site and initially recorded by the surgeon and/or his staff, on primary source documents. The information contained in the source documents was subsequently uploaded to a secure server and then downloaded by the principal investigator (R.M.J.), who organized the information on a standard spreadsheet ( 
Participants
The potentially eligible patients came from the clinical practices of the surgeon investigators and were screened by the surgeons and their staff members as they presented for treatment. The eligibility criteria for participation in the RCT are listed in Table 1 , and each surgeon investigator was required to ascertain participant eligibility. After approximately 8 months of recruitment, we had identified a slower than expected accrual of participants. Therefore, we modified the criteria for participant inclusion in the present study. The initial slow recruitment was, we believe, the result of inclusion criteria that were originally too strict and specifically did not allow for the inclusion of patients with >1 symptomatic HT on their involved foot or patients with adjunct metatarsal and/or bunion deformities that also required surgical treatment. To increase the rate of enrollment, the definition of eligibility for inclusion in the investigation was modified to allow for the inclusion of participants requiring HT correction of the intermediate digits and surgical intervention on the lesser rays (metatarsals and digits) and the first ray (bunionectomy) that did not require non-weightbearing ambulation or cast immobilization. To ascertain the influence this had on our results, we compared the outcomes of the participants enrolled before and after expansion of the protocol inclusion criteria.
Interventions
We compared PIPJ arthrodesis stabilized with either a K-wire or a DCIMSS (Nextra Ò HT Correction System, Nextremity Solutions Ò , Warsaw, IN, and Red Bank, NJ). In every case, the surgery entailed placing the patient supine on the operating table, the use of local anesthesia with intravenous sedation and an ipsilateral ankle tourniquet or anatomic dissection to aid hemostasis, and surgical exposure using either a longitudinal incision or 2 semielliptical skin incisions positioned over the PIPJ of the second, third, or fourth toe, or toes. A transverse incision was then made through the long extensor tendon, capsule, and periosteum, including sectioning of the medial and lateral collateral ligaments. The soft tissues were reflected from the base of the middle and head of the proximal phalanges, enabling visualization of the surfaces in preparation for bone resection. Next, the base of the middle phalanx was resected such that the entire cartilaginous surface and subchondral cortical bone plate were removed. The head of the proximal phalanx was then resected at an angle that ranged from approximately 0 to 10 from dorsally and distally to plantarly and proximally to orient the toe fusion as desired, taking into consideration the 10 of plantar angulation of the DCSSIM implant for the participants randomized to the implantable device (available in 2 forms, 1 with and 1 without 10 of plantarflexion angulation). After preparation of the surfaces to be fused, fixation was undertaken in accordance with the random treatment allocation schedule.
For participants assigned to the K-wire group, a standard 0.045-in. or 0.062-in., trocar-tipped, stainless steel device was used, because this type of K-wire is common to most operating rooms in which bone surgery is undertaken (Fig. 1) . The K-wire was then reamed distally from the proximal IP interface through the middle phalanx and then through the distal phalanx so that it exited the tip of the involved toes. Thereafter, the K-wire was driven from distally to proximally in a retrograde fashion into the proximal phalanx, securing the arthrodesis interface in the desired alignment. The K-wire was then advanced from distal to proximal until the proximal terminal of the K-wire was seated in the base of the proximal phalanx without entering the MTPJ.
For participants assigned to the DCIMSS implant group, dissection and preparation of the PIPJ was undertaken in the same fashion as that described for the K-wire group. The implantable device consisted of an interlocking, stainless steel alloy, with middle and proximal phalangeal components (Fig. 2) . The proximal phalangeal component ranged in diameter from 2.2 mm to 3.2 mm, and measured 12.5 mm in length (with a 5.5-mm stem). The middle phalangeal component measured 11.5 mm long, with a 5.5 mm proximal camshaft stem, and a straight or 10 angular design, with a 6-mm distal threaded segment and a tip that measured 1.5 mm in diameter. The thread diameters measured 3.5, 4.5, or 5.5 mm. The complete intramedullary implant came sterilely packaged in a single-use implant instrument tray that contained a reversible driver and driver handle, 7.5-mm distal cone and proximal cup reamers, a 1.6, 2.8, and 3.5-mm diameter step drill, and a bone holding forceps. The intramedullary implant was inserted in accordance with the manufacturer's instructions (Nextremity Solutions Ò , Warsaw, IN, and Red Bank, NJ; Fig. 3 ).
After placement of the fixation device, for participants in both the K-wire and the DCIMSS implant groups, the surgical wound was closed in anatomic layers, including reapproximation of the long extensor tendon. The choice of suture material and technique and bandaging was performed at the discretion of the operating surgeon. A stiff-soled surgical shoe was used in all patients in the early postoperative period, and this was maintained until clinical and radiographic evidence of arthrodesis were noted and the K-wire was removed or until the surgeon decided that the patient was ready to resume regular shoe gear. The study protocol required those patients allocated to K-wire fixation of the PIPJ arthrodesis to undergo outpatient removal of the wire at the sixth postoperative week. The choices related to prescription of postoperative medications and physical therapy were left to the discretion of the operating surgeon. Our intent was to use a postoperative course of clinical and radiographic follow-up care consistent with standard practice after HT surgery.
Risk Factors and Outcomes
The following baseline demographic exposures were taken into consideration: age (in years), body mass index, gender, race, ethnicity, systemic comorbidity, cigarette smoker status, regular use of systemic medication, the specific involved intermediate toes, multiple intermediate toe involvement, adjunct forefoot (other toe, metatarsal, or bunion) deformity, etiology of the acquired HTs, and the structural length (distance in millimeters) from the palpable base of the proximal phalanx to the tip of toe, with the digit manipulated into a maximally elongated position and not the functional, contracted alignment and circumference (distance in millimeters around the PIPJ or fusion interface) of the involved toe. Study mandated follow-up visits were scheduled at 1 week, 3 weeks, 6 weeks, 3 months, and 6 months postoperatively. At each examination, clinical and radiographic outcome measurements were obtained for the between-group comparisons. Data for the participants who did not attend the 6-month follow-up evaluation were included in the analyses, using the last observation carried forward method. Radiographs in the anteroposterior, lateral, and medial oblique projections were procured at each of the scheduled follow-up visits, and digital files containing these images were uploaded to a secure server and downloaded by the study coordinator who then delivered the images to the nonsurgeon investigators (2 podiatric research fellows and 1 surgical resident) who interpreted the images and categorized the results. The arthrodesis interface was categorized as gapping (no bone-tobone contact observed), contact (bone-to-bone contact without distinct evidence of trabecular bridging), or fused (radiographic evidence of trabecular bridging across the fusion mass; Fig. 4 ). The specific radiographic status was determined by consensus among the 3 nonsurgeon investigators. Foot-related QOL was subjectively measured using 2 patient-reported health measurement instruments, the Bristol Foot Score (BFS) (28) and the Foot Function Index (FFI) (29) . The BFS consists of 15 self-reported items focusing on patient-centered footrelated QOL. The instrument is reliable and known to produce valid information. The patient reads the questionnaire and scores each question numerically. The questions focus on the influence that one's foot had on daily activities during the preceding 2-week period. The score ranges from a minimum of 15 to a maximum of 73 points, with lower scores indicating better foot-related QOL. The FFI consists of 23 self-reported items, divided into 3 subcategories, pain, disability, and activity limitation. Similar to the BFS, the FFI is reliable and known to produce valid information. The patient reads the questionnaire, which is written at the eighth grade level, and scores each question on a scale from 0 (no pain or difficulty) to 10 (worst pain imaginable or so difficult it requires help) that best describes their foot during the preceding week. The pain subcategory consists of 9 items and measures foot pain in different situations, such as walking barefoot versus walking with shoes. The disability subcategory consists of 9 items and measures the difficulty in performing various functional activities because of foot problems, such as difficulty climbing stairs. The activity limitation subcategory consists of 5 items and measures limitations in activities because of foot problems, such as staying in bed all day. Both composite (total) and subcategory scores are calculated.
Adverse events of interest included any intraoperative or postoperative complications, including implant misalignment (violation of the distal cortex of the middle phalangeal head, the proximal phalangeal base, or any portion of the diaphysis of either ossicle) or instability, delayed bone union (complete absence of any trabeculae traversing the fusion mass at the 6-month postoperative radiographic evaluation, viewed on the anteroposterior, lateral, and medial oblique radiographs), infection and/or wound dehiscence, recurrent or new digital deformity, and persistent pain or other symptoms requiring treatment. A serious adverse event was considered any complication that required a return to the operating room for revision surgery of any sort (e.g., debridement, incision and drainage, painful or broken internal fixation, deformity). Adverse events were identified and reported by the operating surgeon and by the third-party, nonsurgeon investigators if they were determined by radiographic inspection.
Statistical Analysis
A variety of statistical procedures, including descriptive and inferential methods, were used to describe the participant patient population, which consisted of all participants enrolled in the investigation and randomized to a treatment arm. An intention-to-treat analysis was used to preserve the bias-limiting influence of random treatment allocation, and the data were analyzed with attention to the type and distribution. The mean AE standard deviation, median, and range were used to describe the demographic and outcome variables. The Wilcoxon rank sum (Mann-Whitney U) test was used to compare the unpaired data (different treatment groups). The incidence of complications and other outcomes of interest is reported in terms of frequency counts and percentages, with attention given to the denominator (the number of PIPJ fusions or the number of patients). Our protocol required inclusion in the analyses of participants with missing outcomes only if their outcomes were imputed (i.e., their outcomes were estimated from other collected information), and only if the number missing comprised ! 10% of the data set for either treatment group, otherwise the last observation was carried forward. Statistical significance was defined at the 5% (p .05) level. Moreover, we considered a 10% difference in the results to be clinically significant. Because this was a postmarketing study of the dual DCIMSS implant (and K-wire fixation), no stopping rules were specified, and the investigating surgeons maintained surveillance of their patients' progress throughout the investigation. The statistical analyses were performed by 1 of us (D.S.M.) who had not operated on any of the patients and had not participated in patient selection, care, or follow-up.
Results
The study flow diagram is depicted in Fig. 5 . Our prospective cohort (both treatment groups combined) included 91 patients (95 PIPJ fusions). Of these patients, 4 (4.34%) underwent PIPJ fusion on 2 separate HTs on the same foot, accounting for 8 of the 95 toes (8.42%). In keeping with the study protocol, for the 4 patients(4.34%) who underwent fusion of 2 separate toes on the same foot, the random treatment allocation determined the intervention to be performed on both of the involved toes (on the same foot). The first participant was enrolled in the study on June 18, 2012 and the last participant on October 14, 2013 (approximately 16 months). Because the stainless steel, intramedullary implant used in the present trial had received U.S. Food and Drug Administration 510K approval on August 28, 2012 and had been used as an IP fusion fixator in clinical practice since then, our investigation was a postmarket study that was not aimed strictly at determining its efficacy and safety.
Baseline Characteristics and Follow-Up Duration by Treatment Group
Random treatment allocation resulted in 48 of the toes (50.53%) undergoing fusion with a K-wire in 46 of the patients (50.55%) and 47 of the toes (49.47%) undergoing fusion with the DCIMSS implant in 45 patients (49.45%). No statistically significant differences were found between the treatment groups in regard to age, body mass index, gender, race, ethnicity, systemic comorbidity, cigarette smoking, systemic medications, involved toe, multiple toe involvement, adjunct forefoot deformities, acquired deformity (as etiology), toe length and circumference, BFS, and FFI at baseline (as would be expected with random treatment allocation), and the follow-up duration ( Table 2 ). Similarly, the differences in the baseline pain, activity, and disability domains of the FFI were neither statistically nor clinically significant between the treatment group ( Because we expanded our original inclusion criteria at approximately 8 months into the trial (Table 1) to allow the inclusion of a wider range of patients (those with concomitant intermediate HTs or metatarsal osteotomies and ipsilateral bunion deformities), we could have imparted a bias that would threaten the validity of our conclusions. Therefore, we compared the outcomes between the patients enrolled before the alteration with the outcomes of those enrolled after the change. We did not observe a difference >5.25% for any outcome of interest. Thus, we believe that the expansion of our inclusion criteria did not impart a substantial bias.
Two patients in the K-wire group (4.35%) and 2 (4.44%) in the intramedullary implant group underwent multiple HT surgery in their involved foot. One participant (1.05% of PIPJ fusion) who had been randomly allocated to fusion with the intramedullary implant actually underwent K-wire fixation but was analyzed in the intramedullary implant group, in keeping with our planned intention-to-treat analysis (which was biased toward the null). Only 1 PIPJ fusion in 1 patient (1.05% of toes, 1.1% of patients, overall) in the K-wire group (2.08% of toes, 2.17% of patients, in the K-wire group) did not attend the 6-month postoperative follow-up visit. However, that participant had been followed up to the 3-month primary efficacy postoperative point.
Outcomes by Treatment Group
Regarding the radiographic outcomes, not every investigating surgeon provided the full complement of protocol-designated radiographs for third-party assessment. The radiographs for 3 patients in the K-wire fixation group were not available for inspection (Table 3) , accounting for 3 of 91 patients overall (3.3%) and 3 of 46 patients (6.52%) in the Kwire fixation group and for 3 of the 95 PIPJ fusions overall (3.16%) and 3 of the 48 of the PIPJ fusions in the K-wire fixation group (6.25%). Furthermore, an additional patient (1 PIPJ fusion) was lost from the Kwire group after 6 weeks postoperatively, for a final radiographic loss to follow-up of 4 of 91 patients overall (4.4%), 4 of 46 patients in the Kwire fixation group (8.7%), and 4 of 95 PIPJ fusions overall (4.21%) and 4 of 48 PIPJ fusions in the K-wire fixation group (8.33%). Despite efforts to procure the radiographic digital imaging files, which had been reviewed by the operating surgeons in regard to the operations, the files were not available for assessment relative to the investigation. The imaging files (CDs) had been inadvertently misplaced by the patients, who were unable to provide them for the purposes of the investigation despite our requests for them to do so. Because protocol allowed for imputation of missing data only if >10% of the data were missing (for either treatment group), we did not impute any data.
Regarding the radiographic appearance of the PIPJ fusion interface, statistically and clinically significantly better phalangeal segment apposition (less gapping and more contact) was observed during the first 6 postoperative weeks (Table 3) . Also, more fusion mass consolidation (i.e., union, incidence of fusion) was observed from the 6-week through the 6-month postoperative follow-up assessments in the intramedullary implant group compared with Abbreviation: K, Kirschner. Data presented as n (%).
* Not every investigating surgeon provided the full complement of protocol-designated radiographs for third-party assessment (loss to analysis and follow-up of <10% of patients and fusions).
y Cuzick's test for trend across ordered groups. z Statistically significantly different.
x Comparing the percentage of fusion sites showing radiographic evidence of a gap, contact, or fusion by treatment group showed clinically significant (>10% to 15%) differences at every follow-up visit, except for the presence of union at 3 weeks postoperatively. Regarding the digital length (Table 4 ) and circumference (Table 5 ) in the treatment groups during the observation period, no statistically or clinically significant differences were identified. Comparisons by treatment group also showed that the toe length and circumference initially decreased and increased, respectively, in the first postoperative week, after which the length remained rather steady. In contrast, the circumference steadily diminished during the remainder of the observation period, regardless of whether the PIPJ fusion had been conducted using a K-wire or an intramedullary implant (Tables 4 and 5) .
For the foot-related QOL outcomes, arthrodesis using a dualcomponent, stainless steel, intramedullary implant resulted in statistically and clinically significantly better BFSs at 1 week postoperatively, with a clinically significantly better BFS at the 3-month postoperative follow-up visit (Table 6, Fig. 6 ). Moreover, arthrodesis with the intramedullary implant resulted in a clinically significantly better composite FFI at the 1-week, 3-week, 3-month, and 6-month postoperative follow-up measurements (Table 7) . A comparison of the FFI subcategories for pain, disability, and activity limitations stratified by treatment group, revealed no statistically significant differences at any time after PIPJ fusion (Tables 8 to 10 ). However, arthrodesis using the intramedullary implant significantly improved the scores clinically compared with standard K-wire fixation in pain relief at 1 and 6 weeks postoperatively, less disability at 1 and 3 weeks postoperatively and 6 months postoperatively, and less limitation of activities at 1 and 3 weeks and 3 and 6 months postoperatively.
Complications
Of the possible adverse events, no cases of implant misalignment or instability, infection (pin tract or otherwise), wound dehiscence, recurrent or new digital deformity, persistent pain or other symptoms requiring treatment or a return to the operating room for revision surgery were observed. Delayed bone union, in the form of clinically stable, fibrous pseudoarthrosis, was observed radiographically in both fixation groups (Table 3) , although the fusions remained clinically stable and thus did not warrant additional intervention.
Discussion
To appreciate the outcomes observed in the present RCT, an understanding of the statistical and clinical significance is needed. A statistically significant outcome is one that is not likely to have resulted from chance. Rather, the measured difference is more likely the result of differences between the interventions (i.e., the use of the intramedullary implant versus standard K-wire fixation in the present investigation). Although statistical significance informs us whether a result is likely to be a chance observation or due to differences between the interventions, it cannot inform us of the magnitude of the difference between the results. Also, statistical significance hinges greatly on the sample size. We powered our sample size estimate according to an expected difference between the interventions (in terms of bone fusion), and this difference was observed in the outcomes we measured.
Clinical significance, however, considers the magnitude of the effect difference, side effect and complication profiles, costs, surgeon comfort with the procedure, patient preferences, spillover effects that affect the patient's family and caretakers, and so forth. For these reasons, clinical significance is an important practical measure of an intervention's influence on an outcome, because it is the benchmark by which clinicians and surgeons reasonably compare differences and decide how to treat patients. Statistical significance might not be meaningful without concomitant clinical significance. For example, a large cohort study (1 with hundreds of patients) could show a statistically significant difference in an outcome according to an age difference of, for example, just 1 year; however, clinically, a 1-year difference in age is not likely to be clinically important (significant) to most surgeons. In general, a clinical difference of !10% will be Data presented as mean (95% confidence interval).
* Wilcoxon rank sum (Mann Whitney U) test for unpaired data. considered clinically significant and worthy of influencing clinical decision-making. In the present study, PIPJ arthrodesis using the implantable, dual-component intramedullary device resulted in clinically significant differences ranging from 10.16% to 25.56% better than standard K-wire fixation for a number of our measured outcomes. [A number of overall effects associated with PIPJ fusion were also observed, and interested readers can review these results in the Supplemental Material at http://www.jfas.org.] Regarding our primary aim of comparing randomly allocated K-wire fixation and dual-component intramedullary implant fixation of the PIPJ for HT correction, the results of our investigation indicated the following effects:
1. The measured baseline demographic variables and risk factors were balanced (neither statistically nor clinically significantly different) between the 2 treatment groups (Table 2 ) 2. The use of the dual-component, stainless steel, intramedullary implant resulted in statistically and clinically significantly less radiographic evidence of phalangeal gapping and more bone-tobone contact throughout the follow-up period and a greater incidence of bone-to-bone union from the 6-week to 6-month observation visits (Table 3) 3. The postoperative changes in toe length (Table 4) and circumference (Table 5) were neither statistically nor clinically significantly different between the 2 treatment groups 4. The use of the dual-component, stainless steel, intramedullary implant resulted in statistically and clinically significantly better BFS scores at the 1-week postoperative measurement and clinically significantly better scores at the 3-month postoperative measurement (Table 6 ) 5. The use of the dual-component, stainless steel, intramedullary implant resulted in clinically significantly better composite FFI scores during the postoperative phase, and this displayed a bimodal course of improvement early in the postoperative phase and again later (1 and 3 weeks and 3 and 6 months), including greater pain relief at 1 and 6 weeks postoperative, less disability at 1 and 3 weeks and 6 months postoperatively, and less limitation of activity at 1 and 3 weeks and 3 and 6 months postoperatively (Tables 7 to 10 ) 6. No cases of implant misalignment or instability, infection (pin tract or otherwise), wound dehiscence, recurrent or new digital deformity, persistent pain or other symptom requiring treatment or a return to the operating room for revision surgery were observed in either fixation group
As previously stated, because of random treatment allocation, we did not expect statistically significant differences in the demographic and risk factor variables between the treatment groups at baseline. Regarding the toe length, we anticipated a similar amount of shortening between the fixation groups, and this was observed. Regarding toe circumference, we expected less swelling with the intramedullary implant owing to less beam flexure and hence more stability at the fusion interface, although a significant difference was not observed. We attributed this to the insensitivity of our measurement technique and reasonable stability achieved with standard, K-wire fixation (and perhaps too small of a sample).
The observation that the intramedullary implant leads to better radiographic evidence of bone-to-bone apposition (less gapping and more contact at the fusion interface) and more prevalent fusion (bony trabecular bridging across the fusion interface) resulted from the ability of the surgeon to seat the proximal and middle phalangeal components of the 2-piece implant to the desired level in each ossicle, thereby creating bone-to-bone contact as soon as the implant components were coupled. The degree of bone-to-bone contact remained constant thereafter, because each component of the implant was screwed into the corresponding phalanx and, as such, could not piston, rotate, or flex. Resistance to flexion, rotation, and pistoning is a feature of certain intramedullary fixation devices that are threaded, those that effect interfragmental compression, and those that are not simply round in the cross-section (15) . If desired, the surgeon could position the components of the intramedullary implant such that, on coupling, a gap will be maintained between the phalangeal surfaces. This might have been desirable in cases in which the surgeon desired the digit to be longer. In such cases, gap healing would be expected and would limited by the distance between the bone surfaces (e.g., in all cases of gap healing). It should also be noted that the dual-component intramedullary implant can be uncoupled and reseated without compromising the integrity of the stability of each part of the implant in the corresponding phalanx, in cases in which the operating surgeon desired such a maneuver. Although it was not a specific aim of our investigation, we observed this gapped alignment on some of the postoperative radiographs.
In contrast, when a K-wire was used to stabilize the arthrodesis, it was driven into the bone and seated to provide splintage by virtue of the elastic modulus of the adjacent bone and the K-wire itself. As such, any weightbearing load applied to the foot would have subjected the Kwire to beam flexure (3-point bending) and perhaps rotation, with the associated loosening that could result in pistoning and the loss of boneto-bone apposition. In general, the interface of the K-wire with bone is most secure when the wire penetrates and purchases the cortical bone. It is less secure in trabecular bone or when the wire has been passed multiple times through the bone (e.g., if redirection of the wire was needed). For these reasons, we believe functional pseudoarthrosis is a common long-term radiographic finding associated with K-wire stabilization of the PIPJ, and this was observed in the patients randomized to K-wire fixation in the present investigation.
It is important to understand that subjective patient outcomes compared with the radiographic and other objective measurements such as toe length or circumference or the presence or absence of a complication are, we believe, the most important measurements of a HT surgical result, because subjective patient outcomes describe to us what matters to patients. Therefore, we chose to use 2 time-honored, reliable methods of measuring patient outcomes (i.e., the BFS and FFI score). These measurement consider what is important to patients (i.e., pain, disability, and activity level), and they specifically focus on the influence the foot has on these outcomes.
Regarding the significantly improved BFS seen early in the postoperative period with the intramedullary implant, this observation was actually hypothesized, based on our expectation that patients without a K-wire protruding from the tip of the operated toe would be subjectively better early in the postoperative phase. That we observed better BFSs at 1 week and 3 months postoperatively with use of the intramedullary implant likely resulted from the absence of a pin protruding from the tip of the operated toe initially and to better bone-to-bone apposition later in the healing phase. This same rationale is most likely the reason we observed better composite and stratified (pain, disability, activity) FFI scores during the entire postoperative observation period when the intramedullary implant was used.
Although the precise association of the radiographic differences we observed with the patient satisfaction scores by treatment group is difficult to ascertain, it is most likely that the better BFSs and FFI scores were associated with better bone-to-bone apposition and union with the dual-component, intramedullary implant.
Another point of interest that is important with the use of a dualcomponent intramedullary implant or any other specialized fixation device designed to stabilize the proximal IP fusion interface, is cost. However, our investigation did not focus at all on costs. It is easy to understand that any specialized fixation device is likely to have a base, per item, crude cost that is substantially greater than that of single (8, 9) or multiple (7) K-wires used to fixate the PIPJ fusion interface. However, it is not at all clear that the use of a K-wire or multiple K-wires will be cost effective compared with a specialty fixation device. Cost effectiveness is difficult to determine and is based on precise estimates of quality-adjusted life-years and incremental cost differences. Even when all goes well, a cost exists related to K-wire protrusion out the distal aspect of the toe and to K-wire removal. A cost is also related to having to uncouple a fused IP interface to retrieve an implanted fixation device, should such a case eventuality arise. Rigorous cost-effectiveness analysis has been shown to favor a more expensive intervention in many cases. For example, with knee osteoarthritis, an intervention that leads to greater physical activity and an associated increase in qualityadjusted life-years would be cost-effective if it costs <$2900 during a 2-year period (30) . Similarly, for hip fracture cases, more expensive treatment at teaching hospitals would be cost-effective compared with the care at nonteaching hospitals because of the lower mortality and greater quality-adjusted life-years (31) . We believe that diligent cost-effectiveness analyses are needed for fixation devices used to fixate the PIPJ fusion interface before a well-founded conclusion can be made regarding such costs. Also, criticism of the use of such devices without rigorous cost-effectiveness analysis would be unconfirmed and groundless.
Study Limitations
A number of recognized methodologic shortcomings could threaten the validity of our conclusions. Regarding the power and sample size estimation, we did not find a published report that had used either the FFI or BFS specifically for digital surgery in the foot. We, therefore, resorted to comparisons of radiographic evidence of arthrodesis. We did so because we were trying to estimate the appropriate number of patients required to identify a statistically significant difference, if one existed. We further estimated that successful fusion was strongly associated with foot-related QOL. We used an estimate that we believed was as good as possible with the existing data published when we were planning the surgical experiment. We also added >10 participants to each arm of the experiment to cushion the estimate and increase the likelihood that a statistically significant difference would be identified. This appears to have been enough for us to note statistically significant differences in some of the outcomes, including our primary outcome of interest (radiographic fusion). However, we might have been able to observe other statistically significant differences in other outcomes if we had had a larger sample in each arm of the investigation (i.e., we might have experienced a type II statistical error).
Our exclusion criteria could have limited the generalizability of our findings, because patients with diabetes, certain other comorbidities, and other exposures were excluded (Table 1) . We made no distinction between PIPJ fusions performed with a 0.062-in. or 0.045-in. K-wire in the K-wire group. Regarding our modification of the inclusion criteria, in which we allowed the enrollment of patients with multiple intermediate HTs and those with metatarsal and bunion deformities that also required surgical care, we believe this alteration of the protocol was responsible for 2 substantial benefits (i.e., more rapid accrual of the study sample and more generalizable results). We believe these are important benefits because they promoted timely accrual of the study population, which is crucial to any clinical investigation (for many reasons), and also increased external validity (generalizability), because concomitant forefoot deformities are commonly addressed by a single trip to the operating room, likely making the outcomes more meaningful to a wider range of foot surgeons. Before this refinement of the inclusion criteria, we were likely to identify a result that would be internally valid (true only within the confines of the clinical experiment) but unlikely to be generalizable, because most patients and surgeons do not usually decide to undertake arthrodesis of a single, intermediate, lesser toe. These modifications led to more patients enrolling with a HT combined with adjunct deformities, and only 4 participants accounted for 2 PIPJ fusions on 1 foot, and these were equally distributed between the K-wire and dual-component, intramedullary implant groups.
Moreover, we did not collect specific information regarding the precise duration of K-wire use before the wire was actually removed (although the investigational protocol called for wire removal at 6 weeks postoperatively). Also, we did not report the precise point after surgery at which patients resumed regular shoe wear and returned to their regular activities. Although we have described the radiographic and clinical findings and foot-related QOL at specified points after surgery, we appreciate that the aforementioned additional information (duration of K-wire placement, time to return to regular shoes and activities) would be useful to surgeons treating patients with HTs. However, the foot-related QOL measurements likely accounted for any clinical influences that such differences would have made.
Although we did not include in the present study any patients who required MTPJ transfixation, we realize that sequential release of HT deformity often entails temporary pin fixation of the realigned proximal phalanx base on the metatarsal head. It is, however, reasonable to consider temporary transfixation of the MTPJ, if necessary, in conjunction with PIPJ fusion using the dual-component, intramedullary implant and an additional K-wire percutaneously directed from the metatarsal into the base of the proximal phalanx. (We used this maneuver outside the confines of the present RCT, which did not investigate such a surgical scenario. We believe that if MTPJ transfixation is indicated, surgeons should consider using a Kwire made of the same alloy as the implant and avoid direct contact between the K-wire and the intramedullary implant, because galvanic and fretting corrosion between dissimilar or in-contact metals are potential problems, particularly if the implants are retained in the aqueous environment of the tissues for a long period. The use of an axial, intramedullary K-wire to transfix the PIPJ fusion and stabilize a realigned MTPJ would obviate the concern for galvanic or fretting corrosion.) Despite this exclusion, we believe that the participants in the present investigation were, overall, typical patients seeking treatment of symptomatic HTs.
Furthermore, because 2 patients (4.35%) in the K-wire group and 2 patients (4.44%) in the dual-component, intramedullary implant group underwent HT surgery on 2 toes on their operated foot, the principle of data independence and our randomization table were violated to some degree, which could have influenced our results despite our efforts (our sample size estimate) to recruit enough volunteer participants in each treatment group. Although our statistical tests assumed the lack of an association, 8 of the 95 toes (8.42%) were actually linked by patient. This limitation was acceptable to us, because it affected <10% of the toes analyzed, it enabled us to accrue participants more rapidly, and it added to the generalizability of our results.
Still further, we realize that surgeon investigators who were not blinded to treatment allocation determined whether a complication was present, and the participating patients also knew which treatment they had received. We tried to limit the biases related to our inability to mask these assessors from knowing the treatment allocation with the use of foot-related QOL outcome measures known to produce valid information and hinge on a patient's subjective assessment of their status (BFS and FFI, which considers pain). Regarding the radiographic outcomes, nonoperating surgeons (1 resident and 2 research fellows) interpreted and categorized the appearance of the PIPJ fusion on the radiographic images. Regarding the determination of the incidence of postoperative complications, this was left to the operating surgeon. We believe this was in keeping with standard surgical practice and made the results generalizable.
We further observed that 1 patient randomized to the dualcomponent, intramedullary implant group actually underwent K-wire fixation of the PIPJ at the surgeon's discretion. This patient's data were, in accordance with our investigational protocol, analyzed with the intramedullary implant group. This type of intention-to-treat analysis biases toward the null and, as such, predisposed our findings toward a type II statistical error. We also lost 1 patient (1.05% of PIPJ fusions, 1.1% of patients, overall) in the K-wire group (2.08% of PIPJ fusions, 2.17% of patients, in the K-wire group) to the final 6-month follow-up examination, although we did have every randomized participant followed up to the primary efficacy endpoint of 3 months. We believe 3 months postoperatively was an important postoperative point because successful arthrodesis should have been achieved by that point after surgery. Still further, regarding information bias, not every participant underwent the full spectrum of planned postoperative radiographs. We observed a final radiographic loss to follow-up of 4 of 91 patients overall (4.4%) and 4 of 46 patients in the K-wire fixation group (8.7%), which accounted for 4 of 95 PIPJ fusions overall (4.21%) and 4 of 48 PIPJ fusions in the K-wire fixation group (8.33%). As such, none of the loss to follow-up, neither in terms of patients or radiographs, exceeded 8.7%. Despite these information biases, we do not believe that our loss to follow-up represented a substantial threat to the validity of our conclusions.
Finally, regarding the limitations, we realize that a longer followup duration would always be better when describing the results of surgery. For the purposes of the present investigation, however, we restricted the follow-up duration to 6 months, because we hypothesized that any differences in clinical outcomes between the treatment groups would have been noted early in the postoperative phase. Also, we believe that patients who undergo HT repair should have adequately healed and have reaped the benefits of the surgery by 3 to 6 months postoperatively.
In conclusion, the results of the present investigation have shown that arthrodesis using a dual-component, stainless steel, intramedullary implant statistically and clinically significantly showed more prevalent bone-to-bone apposition and union within the first 6 postoperative months and also resulted in better patient-oriented footrelated QOL in the early (first 6 months) postoperative period as measured using the BFS and FFI. We believe that the use of the implanted fixation device was associated with less flexion across the fusion interface and, hence, better radiographic and clinical evidence of fusion. Moreover, we believe that the absence of a pin sticking out the end of the toe early in the postoperative phase further contributed to the better foot-related QOL results. The cost effectiveness of the dualcomponent, intramedullary implant remains to be measured, and future work is necessary to establish a causal relationship between the fixation device and patient outcomes. We also believe that the results of the present RCT could be used to guide future investigators interested in exploring the outcomes after HT surgery.
